Plain-English translation of NCT05949580 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing whether two digital tools working together can improve how doctors care for people with relapsing-remitting multiple sclerosis. The first tool uses artificial intelligence to analyze your MRI brain scans and track subtle changes over time. The second tool is a smartphone app and doctor portal that lets you track your symptoms and medications, and helps your care team stay updated on your health between visits.
Doctors want better ways to catch early changes in multiple sclerosis and keep patients connected to their care team. This study is testing whether digital tools can help doctors spot disease progression earlier and give more personalized care.
You likely qualify if…
You likely don't qualify if…
You would download the icompanion patient app on your smartphone and use it regularly to log your symptoms, medications, and health updates. Your doctors would have access to this information through a secure portal, along with your MRI scans and brain imaging reports. You and your care team would fill out questionnaires about your health. The study involves about 500 people total, and your participation helps researchers understand whether these digital tools make MS care better and easier to manage.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Germany